{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T05:08:35Z","timestamp":1679375315366},"reference-count":21,"publisher":"Georg Thieme Verlag KG","issue":"07","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1055\/a-1847-2500","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T23:36:35Z","timestamp":1679355395000},"page":"371-379","source":"Crossref","is-referenced-by-count":0,"title":["Management des Prolaktinoms vor, w\u00e4hrend und nach der Schwangerschaft"],"prefix":"10.1055","volume":"148","author":[{"given":"Stephan","family":"Petersenn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"101290","DOI":"10.1016\/j.beem.2019.101290","article-title":"The epidemiology, diagnosis and treatment of Prolactinomas:The old and the new","volume":"33","author":"P Chanson","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and Treatment of Pituitary Adenomas: A Review","volume":"317","author":"ME Molitch","year":"2017","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11102-019-01024-z","article-title":"Biochemical diagnosis in prolactinomas: some caveats","volume":"23","author":"S Petersenn","year":"2020","journal-title":"Pituitary"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.4158\/EP-2020-0260","article-title":"Role of Cannulated Prolactin Test in Evaluation of Hyperprolactinemia \u2013 A Retrospective Study","volume":"26","author":"A Tsur","year":"2020","journal-title":"Endocr Pract"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11102-019-01001-6","article-title":"Magnetic resonance imaging in the management of prolactinomas; a review of the evidence","volume":"23","author":"EV Varlamov","year":"2020","journal-title":"Pituitary"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2019.3.JNS19121","article-title":"Prolactinomas and nonfunctioning adenomas: preoperative diagnosis of tumor type using serum prolactin and tumor size","author":"WT Burke","year":"2019","journal-title":"J Neurosurg"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s11102-022-01246-8.","article-title":"Prolactin immunoassay: does the high-dose hook effect still exist?","volume":"25","author":"V Raverot","year":"2022","journal-title":"Pituitary"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000495775","article-title":"Management of Dopamine Agonist-Resistant Prolactinoma","volume":"109","author":"D Maiter","year":"2019","journal-title":"Neuroendocrinology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e686","DOI":"10.1016\/j.wneu.2019.05.249","article-title":"Radiographic and Hormonal Regression in Prolactinomas: An Analysis of Treatment Failure","volume":"129","author":"OO Akinduro","year":"2019","journal-title":"World Neurosurg"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"dgz076105","DOI":"10.1210\/clinem\/dgz076","article-title":"Impulse Control Disorders in Dopamine Agonist-Treated Hyperprolactinemia: Prevalence and Risk Factors","volume":"105","author":"SMC De Sousa","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1210\/clinem\/dgaa882","article-title":"Incidence of Cabergoline-Associated Valvulopathy in Primary Care Patients With Prolactinoma Using Hard Cardiac Endpoints","volume":"106","author":"CE Stiles","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1210\/jc.2009-1238","article-title":"Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis","volume":"95","author":"OM Dekkers","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11102-014-0617-2","article-title":"Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis","volume":"18","author":"J Hu","year":"2015","journal-title":"Pituitary"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1210\/clinem\/dgz144","article-title":"Surgery as a Viable Alternative First-Line Treatment for Prolactinoma Patients. A Systematic Review and Meta-Analysis","volume":"105","author":"AH Zamanipoor Najafabadi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1055\/a-1247-4908","article-title":"Outcomes of Transsphenoidal Microsurgery for Prolactinomas \u2013 A Contemporary Series of 162 Cases","volume":"129","author":"S Giese","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","article-title":"Advances in the treatment of prolactinomas","volume":"27","author":"MP Gillam","year":"2006","journal-title":"Endocr Rev"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1055\/a-0794-7587","article-title":"Pituitary Disease in Pregnancy: Special Aspects of Diagnosis and Treatment","volume":"79","author":"S Petersenn","year":"2019","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ecl.2019.05.004","article-title":"Pituitary Tumors in Pregnancy","volume":"48","author":"W Huang","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11102-019-01008-z","article-title":"A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas","volume":"23","author":"BG Sant\u2019 Anna","year":"2020","journal-title":"Pituitary"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-21-0462","article-title":"ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy","volume":"185","author":"A Luger","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.23736\/S0391-1977.17.02792-4","article-title":"Prolactinomas: how to handle prior to and during pregnancy?","volume":"43","author":"A Glezer","year":"2018","journal-title":"Minerva Endocrinol"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1847-2500.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T23:37:05Z","timestamp":1679355425000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1847-2500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":21,"journal-issue":{"issue":"07","published-online":{"date-parts":[[2023,3,20]]},"published-print":{"date-parts":[[2023,3]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1847-2500","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}